Tenax Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $5 |
Gross Profit | -1 | 1 | |
EBITDA | -3,565 | -3,790 | -3,218 |
EBIT | -3,566 | -3,792 | -3,223 |
Net Income | -3,575 | 3,798 | -3,225 |
Net Change In Cash | 0 | 0 | 5 |
Free Cash Flow | -3,031 | -5,165 | -1,172 |
Cash | 9,384 | 12,549 | 9,792 |
Basic Shares | 1,958 | 1,219 | 298 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7 | -113 | -108 | -114 |
EBITDA | -8,226 | -10,930 | -32,364 | -9,735 |
EBIT | -8,233 | -11,043 | -32,473 | -9,849 |
Net Income | -7,710 | -11,043 | -32,730 | -9,871 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 1,344 | |||
Free Cash Flow | -5,903 | -12,015 | -10,861 | -9,276 |
Cash | 9,792 | 2,123 | 5,583 | 6,250 |
Basic Shares | 248 | 18 | 12 | 6 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.19 |
2024-06-30 | -$1.83 |
2024-03-31 | -$3.12 |
2023-12-31 | -$12.98 |
